机械性宫颈扩张联合米索前列醇与单用米索前列醇促宫颈成熟的母婴结局:系统综述与荟萃分析
该系统综述纳入11项随机对照试验,比较机械性宫颈扩张联合米索前列醇与单用米索前列醇促宫颈成熟的效果。联合组分娩时间更短、新生儿重症监护病房入住率更低,剖宫产率两组无差异。
要点
- 联合组剖宫产率与单用米索前列醇组无差异(RR 0.95,95%CI 0.80-1.13)。
- 联合组总分娩时间更短(均差-3.65小时,95%CI 5.23至-2.07)。
- 联合组新生儿重症监护病房入住风险更低(RR 0.71,95%CI 0.53-0.96)。
核心结论
- 机械性宫颈扩张联合米索前列醇促宫颈成熟与更短的分娩时间、相似的剖宫产率及更低的新生儿重症监护病房入住率相关。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、EMBASE和Web-of-Science数据库(从建库至检索截止日期2018年12月31日)。
- 纳入单胎活胎、需促宫颈成熟(Bishop≤7)引产的随机对照试验。
- 共纳入11项试验,联合组922例,单用米索前列醇组947例。
主要发现
- 剖宫产率两组无差异(RR 0.95,95%CI 0.80-1.13)。
- 联合组总分娩时间更短(均差-3.65小时,95%CI 5.23至-2.07),阴道分娩时间更短(均差-4.53小时,95%CI -5.79至-3.27)。
- 联合组新生儿重症监护病房入住风险更低(RR 0.71,95%CI 0.53-0.96),胎粪污染羊水风险更低(RR 0.62,95%CI 0.43-0.90)。
- 联合组伴胎心监护异常的心动过速风险更低(RR 0.53,95%CI 0.30-0.94),特布他林使用更少(RR 0.63,95%CI 0.47-0.85)。
- 子宫内膜炎(RR 1.07,95%CI 0.43-2.61)和绒毛膜羊膜炎(RR 1.58,95%CI 0.88-2.84)风险两组相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE DATA: The aim of the present systematic review was to investigate the efficacy and safety of cervical ripening for the combination of mechanical dilation and misoprostol administration compared with misoprostol alone by evaluating 2 primary outcomes: time to delivery and rate of cesarean delivery. STUDY: The Medline, EMBASE, and Web-of-Science electronic databases (from conception to end-of-search date December 31, 2018) were searched systematically. Randomized controlled trials that included patients with a singleton viable fetus who underwent induction of labor that required cervical ripening with an unfavorable cervix (Bishop ≤7) were eligible for inclusion. STUDY APPRAISAL AND SYNTHESIS METHODS: Data were pooled with the use of the random effects and fixed effects model after the assessment for the presence of heterogeneity. Risk of bias for each included study was assessed based on the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions. RESULTS: Eleven trials met the inclusion criteria and included a total of 922 and 947 subjects in the combination and misoprostol-only groups, respectively. There was no difference in the incidence of cesarean delivery between the 2 groups (relative risk, 0.95; 95% confidence interval, 0.80-1.13). The combination of mechanical dilation and misoprostol resulted in overall shorter time to delivery (mean difference, -3.65 hours; 95% confidence interval, 5.23 to -2.07), shorter time to vaginal delivery (mean difference, -4.53 hours; 95% confidence interval, -5.79 to -3.27), lower risk of neonatal intensive care unit admission (relative risk, 0.71; 95% confidence interval, 0.53-0.96), meconium-stained fluid (relative risk, 0.62; 95% confidence interval, 0.43-0.90), tachysystole with fetal heart trace changes (relative risk, 0.53; 95% confidence interval, 0.30-0.94), and terbutaline use (relative risk, 0.63; 95% confidence interval, 0.47-0.85) compared with the use of misoprostol alone. Risk of endometritis (relative risk, 1.07; 95% confidence interval, 0.43-2.61) and chorioamnionitis (relative risk, 1.58; 95% confidence interval, 0.88-2.84) was comparable between the 2 groups. CONCLUSION: The combination of mechanical cervical dilation with misoprostol for cervical ripening is associated with a shorter time to delivery, a similar rate of cesarean delivery, and a lower incidence of neonatal intensive care unit admission compared with the use of misoprostol alone.
引用
- Nasioudis D, Kim SW, Schoen C, et al. Maternal and neonatal outcomes with mechanical cervical dilation plus misoprostol compared to misoprostol alone for cervical ripening; a systematic review of literature and metaanalysis. Am J Obstet Gynecol MFM. 2019. PMID: 33345815. doi:10.1016/j.ajogmf.2019.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。